Loading
AP
Aequus Pharmaceuticals Inc. Stock: price and insider trades · Canada
Aequus Pharmaceuticals Inc.: what insiders have been doing
Aequus Pharmaceuticals Inc. is a listed company. Its directors and officers file their transactions with SEDI. No insider at Aequus Pharmaceuticals Inc. has published a filing in the past twelve months. The most recent one dates from 21 October 2025.
Since 2016, the database holds 60 purchases and 4 sales by insiders of the company.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
77
Thresholds
n/a
Buy Volume
€318,655
60 ops. · all time
Sell Volume
€4,017
4 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 21 October 2025
Declarations77 total
490,000 shares@ CA$0.01515.0% of flowCommon SharesTSXSEDI:4594706
Canonical exit: 24 Jul 2024 (T+90)
391,000 shares@ CA$0.0215.9% of flowCommon SharesTSXSEDI:4594704
Canonical exit: 2 Jun 2024 (T+90)
1,000 shares@ CA$0.0150.0% of flowCommon SharesTSXSEDI:4594702
Canonical exit: 30 May 2024 (T+90)
108,000 shares@ CA$0.0153.3% of flowCommon SharesTSXSEDI:4594700
Canonical exit: 29 May 2024 (T+90)
88,000 shares@ CA$0.035.7% of flowCommon SharesTSXSEDI:4594696
Canonical exit: 19 Feb 2023 (T+90)
12,000 shares@ CA$0.030.8% of flowCommon SharesTSXSEDI:4594695
Canonical exit: 16 Feb 2023 (T+90)
100,000 shares@ CA$0.03256.6% of flowCommon SharesTSXSEDI:4594699
Canonical exit: 28 Jan 2024 (T+90)
265,000 shares@ CA$0.02513.6% of flowCommon SharesTSXSEDI:4594698
Canonical exit: 16 Mar 2023 (T+90)
Common SharesTSXSEDI:4594697
115,000 shares@ CA$0.030.5% of flowCommon SharesTSXSEDI:4035647
Canonical exit: 18 Feb 2023 (T+90)
285,000 shares@ CA$0.04Common SharesTSXSEDI:4035648
Canonical exit: 28 Feb 2023 (T+90)
10,000 shares@ CA$0.062.2% of flowCommon SharesTSXSEDI:3999208
Canonical exit: 5 Dec 2022 (T+90)
47,000 shares@ CA$0.0711.8% of flowCommon SharesTSXSEDI:3999210
Canonical exit: 6 Dec 2022 (T+90)
6,666,666 shares@ CA$0.15Common SharesTSXSEDI:3994251
120,000 shares@ CA$0.0748.8% of flowCommon SharesTSXSEDI:3994081
Canonical exit: 18 Oct 2022 (T+90)
26,000 shares@ CA$0.0710.5% of flowCommon SharesTSXSEDI:3994083
Canonical exit: 20 Oct 2022 (T+90)
64,000 shares@ CA$0.0726.0% of flowCommon SharesTSXSEDI:3994084
Canonical exit: 23 Oct 2022 (T+90)
4,000 shares@ CA$0.071.6% of flowCommon SharesTSXSEDI:3994082
Canonical exit: 19 Oct 2022 (T+90)
16,000 shares@ CA$0.065.6% of flowCommon SharesTSXSEDI:3994085
Canonical exit: 23 Oct 2022 (T+90)
20,000 shares@ CA$0.0657.5% of flowCommon SharesTSXSEDI:3994086
Canonical exit: 23 Oct 2022 (T+90)
Common SharesTSXSEDI:3994080
100,000 shares@ CA$0.075Common SharesTSXSEDI:3979932
Canonical exit: 18 Oct 2022 (T+90)
1,000 shares@ CA$0.08Common SharesTSXSEDI:3979597
Canonical exit: 17 Oct 2022 (T+90)
99,000 shares@ CA$0.07Common SharesTSXSEDI:3979595
Canonical exit: 17 Oct 2022 (T+90)
5,000 sharesCommon SharesTSXSEDI:3920931
25 of 77 declarations
About Aequus Pharmaceuticals Inc.
Aequus Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of innovative pharmaceutical products. It is listed on the Toronto Stock Exchange under the symbol XTSE.
